Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.61 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.61 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.61 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.61 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.61 |
| ▸ | IL1RN | P18510 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30433621 | 0.97 | OPRM1 (0.62) | ERAP1ERAP2LNPEPOPRM1OPRD1 | |
| SCHEMBL29577875 | 0.95 | OPRM1 (0.66) | ERAP1ERAP2LNPEPOPRM1OPRD1 | |
| SCHEMBL30781561 | 0.95 | ERAP1 (0.66) | ERAP1ERAP2LNPEPOPRM1OPRD1 | |
| SCHEMBL11835619 | 0.95 | ERAP1 (0.66) | ERAP1ERAP2LNPEPOPRM1OPRD1 | |
| SCHEMBL29365261 | 0.95 | ERAP1 (0.66) | ERAP1ERAP2LNPEPOPRM1OPRD1 | |
| SCHEMBL21641796 | 0.95 | ERAP1 (0.66) | ERAP1ERAP2LNPEPOPRM1OPRD1 | |
| SCHEMBL30011658 | 0.94 | ERAP1 (0.66) | ERAP1ERAP2LNPEPOPRM1OPRD1 | |
| SCHEMBL29577265 | 0.94 | ERAP1 (0.66) | ERAP1ERAP2LNPEPOPRM1OPRD1 | |
| SCHEMBL30010730 | 0.94 | ERAP1 (0.66) | ERAP1ERAP2LNPEPOPRM1OPRD1 | |
| SCHEMBL29577861 | 0.94 | OPRM1 (0.67) | ERAP1ERAP2LNPEPOPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119454497-A | Application of kenaf peptide and salt thereof in cosmetics | 上海湃肽生物科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118021645-A | Application of kenaf peptide and derivative thereof in cosmetics | 上海湃肽生物科技有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-119454497-A | Application of kenaf peptide and salt thereof in cosmetics | 上海湃肽生物科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-118021645-A | Application of kenaf peptide and derivative thereof in cosmetics | 上海湃肽生物科技有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-117327155-A | Method for preparing LHRH analogue by solid-liquid phase combination | 南京星银药业集团有限公司 | 2024-01-02 | — | — | CN | disclosed |
| WO-2023030278-A1 | FULL-LIQUID-PHASE SYNTHESIS METHOD FOR REELIN DRUG | 湖南三太药业有限公司 | 2023-03-09 | — | — | WO | disclosed |
| WO-2023030278-A1 | FULL-LIQUID-PHASE SYNTHESIS METHOD FOR REELIN DRUG | 湖南三太药业有限公司 | 2023-03-09 | — | — | WO | disclosed |
| WO-2023030277-A1 | METHOD FOR FULLY LIQUID-PHASE SYNTHESIS OF GRNH NONAPEPTIDE AMIDE ANALOG | 湖南微肽生物医药有限公司 | 2023-03-09 | — | — | WO | disclosed |
| WO-2023030277-A1 | METHOD FOR FULLY LIQUID-PHASE SYNTHESIS OF GRNH NONAPEPTIDE AMIDE ANALOG | 湖南微肽生物医药有限公司 | 2023-03-09 | — | — | WO | disclosed |
| EP-0432022-B1 | Medium for reaction and dissolution of peptides and process of peptide synthesis by making use of said medium | RHONE POULENC CHIMIE (FR) | 1996-10-23 | — | — | EP | disclosed |
| EP-0432022-A1 | Medium for reaction and dissolution of peptides and process of peptide synthesis by making use of said medium | RHONE-POULENC CHIMIE (FR) | 1991-06-12 | — | — | EP | disclosed |
| US-3963691-A | POLYPEPTIDES, PEPTIZATION | MERCK & CO., INC. (US) | 1976-06-15 | — | — | US | disclosed |